Genexine, Inc.
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
095700 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크, 강서구
- Website:
- http://www.genexine.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Genexine, Inc. is a clinical-stage biopharmaceutical company focused on the research and development of innovative immunotherapeutics and next-generation biologics. The company leverages its proprietary hyFc® platform technology to create long-acting treatments. Its primary focus areas are immuno-oncology and rare diseases. Key pipeline assets include GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for cancer therapy, as well as late-stage candidates GX-E4 for anemia and GX-H9 for growth hormone deficiency. Genexine aims to develop novel and "bio-better" drugs to address serious health issues and improve patient outcomes.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Genexine, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Genexine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Genexine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
